Brooks
Life Science Systems, a division of Brooks Automation, Inc. a worldwide
provider of automation, vacuum, and instrumentation solutions for
multiple markets, today announced the initiation of a technology
development and commercialization partnership with The Scripps Research
Institute.
The
cornerstone of this partnership will be a Brooks and Scripps Research
exclusive licensing agreement to jointly complete the development of a
microplate imaging system created by Scripps Research and to enable
Brooks to manufacture and commercialize this imaging system. This Brooks
Life Science Systems “Plate Auditor” will be used by pharmaceutical and
biotech compound management and high throughput screening (HTS) groups
to evaluate the quality of the compound samples prepared in microplates
for use in drug discovery HTS activities.
“This
technology was developed to address an unmet need in our compound
management operation—the automated assessment of compound quality in
plate-based HTS libraries,” said Peter Hodder, PhD, senior director and
head of lead identification at the Florida campus of Scripps Research.
“Both HTS and compound management staff now consider it indispensable
for routine quality control of cherry-picked samples as well as periodic
monitoring of sample quality across all our screening libraries.”
